Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage during Angioplasty-Bleeding Study)

American Journal of Cardiology

Volumn 107, Issue 7, 2011, Pages 995-1000

  Patti, Giuseppe ^a   Pasceri, Vincenzo ^b   Vizzi, Vincenzo ^a   Ricottini, Elisabetta ^a   Di Sciascio, Germano ^a  

^a UNIVERSITY OF ROME   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; HIRULOG;

AGED; ANGINA PECTORIS; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; CORRELATION ANALYSIS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INCIDENCE; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POINT OF CARE TESTING; PREOPERATIVE CARE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; THROMBOCYTE FUNCTION;

ACUTE CORONARY SYNDROME; AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY THROMBOSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMORRHAGE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; POINT-OF-CARE SYSTEMS; PREDICTIVE VALUE OF TESTS; PREMEDICATION; PROSPECTIVE STUDIES; RECEPTORS, PURINERGIC P2Y12; STENTS; TICLOPIDINE;

EID: 79952767495     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.11.025     Document Type: Article

References (30)

1. P.A. Gurbel, K.P. Bliden, B.L. Hiatt, and C.M. O'Connor Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity Circulation 107 2003 2908 2913 (Pubitemid 36736631)
2. V.L. Serebruany, S.R. Steinhubl, P.B. Berger, A.I. Malinin, D.L. Bhatt, and E.J. Topol Variability in platelet responsiveness to clopidogrel among 544 individuals J Am Coll Cardiol 45 2005 246 251 (Pubitemid 40094733)
3. G. Patti, A. Nusca, F. Mangiacapra, L. Gatto, A. D'Ambrosio, and G. Di Sciascio Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention Results of the ARMYDA-PRO (Antiplatelet Therapy for Reduction of Myocardial Damage During AngioplastyPlatelet Reactivity Predicts Outcome) study J Am Coll Cardiol 52 2008 1128 1133
4. W. Hochholzer, D. Trenk, H.P. Bestehorn, B. Fischer, C.M. Valina, M. Ferenc, M. Gick, A. Caputo, H.J. Bttner, and F.J. Neumann Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement J Am Coll Cardiol 48 2006 1742 1750 (Pubitemid 44648629)
5. K.P. Bliden, J. DiChiara, U.S. Tantry, A.K. Bassi, S.K. Chaganti, and P.A. Gurbel Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate? J Am Coll Cardiol 49 2007 657 666 (Pubitemid 46205039)
6. G. Ndrepepa, P.B. Berger, J. Mehilli, M. Seyfarth, F.J. Neumann, A. Schmig, and A. Kastrati Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point J Am Coll Cardiol 51 2008 690 697 (Pubitemid 351221218)
7. G. Patti, G. Colonna, V. Pasceri, L. Lassandro Pepe, A. Montinaro, and G. Di Sciascio Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) study Circulation 111 2005 2099 2106 (Pubitemid 40577905)
8. G. Patti, M. Chello, V. Pasceri, D. Colonna, A. Nusca, M. Miglionico, A. D'Ambrosio, E. Covino, and G. Di Sciascio Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs substudy J Am Coll Cardiol 48 2006 1560 1566 (Pubitemid 44528186)
9. G. Patti, V. Pasceri, G. Colonna, M. Miglionico, D. Fischetti, G. Sardella, A. Montinaro, and G. Di Sciascio Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial J Am Coll Cardiol 49 2007 1272 1278 (Pubitemid 46467240)
10. G. Di Sciascio, G. Patti, V. Pasceri, A. Gaspardone, G. Colonna, and A. Montinaro Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) randomized trial J Am Coll Cardiol 54 2009 558 565
11. G. Di Sciascio, G. Patti, V. Pasceri, G. Colonna, F. Mangiacapra, and A. Montinaro Clopidogrel reloading in patients undergoing percutaneous coronary intervention on chronic clopidogrel therapy Results of the ARMYDA-4 RELOAD (Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty) randomized trial Eur Heart J 31 2010 1337 1343
12. A. Malinin, A. Pokov, L. Swaim, M. Kotob, and V. Serebruany Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrel Methods Find Exp Clin Pharmacol 28 2006 315 322 (Pubitemid 44047198)
13. A.K. Rao, C. Pratt, A. Berke, A. Jaffe, I. Ockene, T.L. Schreiber, W.R. Bell, G. Knatterud, T.L. Robertson, and M.L. Terrin Thrombolysis In Myocardial Infarction (TIMI) TrialPhase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase J Am Coll Cardiol 11 1988 1 11 (Pubitemid 18029027)
14. P.A. Gurbel, K.P. Bliden, K. Guyer, P.W. Cho, K.A. Zaman, R.P. Kreutz, A.K. Bassi, and U.S. Tantry Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING study J Am Coll Cardiol 46 2005 1820 1826 (Pubitemid 41579802)
15. W.C. Lau, L.A. Waskell, P.B. Watkins, C.J. Neer, K. Horowitz, A.S. Hopp, A.R. Tait, D.G. Carville, K.E. Guyer, and E.R. Bates Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction Circulation 107 2003 32 37 (Pubitemid 36070929)
16. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, C. Ramrez, U. Cavallari, E. Trabetti, M. Sabat, R. Hernndez, R. Moreno, J. Escaned, F. Alfonso, C. Bauelos, M.A. Costa, T.A. Bass, P.F. Pignatti, and C. Macaya Contribution of gene sequence variations of the hepatic cytochrome P450 3A4 enzyme to variability in individual responsiveness to clopidogrel Arterioscler Thromb Vasc Biol 26 2006 1895 1900 (Pubitemid 44305347)
17. D. Sibbing, W. Koch, D. Gebhard, T. Schuster, S. Braun, J. Stegherr, T. Morath, A. Schmig, N. von Beckerath, and A. Kastrati Cytochrome 2C19 (*)17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement Circulation 121 2010 512 518
18. W.C. Lau, P.A. Gurbel, P.B. Watkins, C.J. Neer, A.S. Hopp, D.G. Carville, K.E. Guyer, A.R. Tait, and E.R. Bates Contribution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance Circulation 109 2004 166 171 (Pubitemid 38114134)
19. M.J. Price, S. Endemann, R.R. Gollapudi, R. Valencia, C.T. Stinis, J.P. Levisay, A. Ernst, N.S. Sawhney, R.A. Schatz, and P.S. Teirstein Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation Eur Heart J 29 2008 992 1000 (Pubitemid 351844676)
20. R. Marcucci, A.M. Gori, R. Paniccia, B. Giusti, S. Valente, C. Giglioli, P. Buonamici, D. Antoniucci, R. Abbate, and G.F. Gensini Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up Circulation 119 2009 237 242
21. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, K.K. Fox Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
22. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, F.J. Neumann, D. Ardissino, S. De Servi, S.A. Murphy, J. Riesmeyer, G. Weerakkody, C.M. Gibson, E.M. Antman TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015 (Pubitemid 350106708)
23. L. Wallentin, R.C. Becker, A. Budaj, C.P. Cannon, H. Emanuelsson, C. Held, J. Horrow, S. Husted, S. James, H. Katus, K.W. Mahaffey, B.M. Scirica, A. Skene, P.G. Steg, R.F. Storey, R.A. Harrington PLATO Investigators A. Freij, and M. Thorsn Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
24. S.V. Rao, J.A. Eikelboom, C.B. Granger, R.A. Harrington, R.M. Califf, and J.P. Bassand Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1193 1204 (Pubitemid 47343833)
25. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
26. F. Mangiacapra, E. Barbato, G. Patti, L. Gatto, V. Vizzi, E. Ricottini, A. D'Ambrosio, W. Wijns, and G. Di Sciascio Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention JACC Cardiovasc Interv 3 2010 318 323
27. D. Sibbing, S. Schulz, S. Braun, T. Morath, J. Stegherr, J. Mehilli, A. Schmig, N. von Beckerath, and A. Kastrati Antiplatelet effects of clopidogrel and bleeding in patients undergoing coronary stent placement J Thromb Haemost 8 2010 250 256
28. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J. Ruven, E.T. Bal, V.H. Deneer, A.M. Harmsze, J.A. van der Heyden, B.J. Rensing, M.J. Suttorp, C.M. Hackeng, and J.M. ten Berg Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
29. P. Agostoni, G.G. Biondi-Zoccai, M.L. de Benedictis, S. Rigattieri, M. Turri, M. Anselmi, C. Vassanelli, P. Zardini, Y. Louvard, and M. Hamon Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures; Systematic overview and meta-analysis of randomized trials J Am Coll Cardiol 44 2004 349 356 (Pubitemid 38950594)
30. D. Sibbing, S.R. Steinhubl, S. Schulz, A. Schomig, and A. Kastrati Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: initial evidence of a therapeutic window J Am Coll Cardiol 56 2010 317 318